US Healthcare Reform and China

Now that the US Healthcare Reform bill has become law, we know that more people are (or eventually will be) insured, but we don’t know the larger ramifications of the package. In particular, we suspect that the government will eventually seek greater control over the life science industry – costs are at the center of healthcare – but we don’t know how or when or what segments of the industry will be most affected. We can, however, plan on China continuing to factor more prominently in the US life science industry. More details...